Trials / Completed
CompletedNCT05591144
Short-term Oral Prednisone for Acute Subjective Tinnitus
Investigating the Efficacy of Short-term Oral Prednisone Therapy on Acute Subjective Tinnitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 146 (actual)
- Sponsor
- Eye & ENT Hospital of Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to investigate the efficacy of oral steroids in the acute tinnitus population. Participants will receive appropriate dosages of short-term prednisone and/or oral Ginkgo Biloba tablets.
Detailed description
Researchers will compare the intervention group and placebo-control group to see whether short-term systemic steroid therapy is effective for acute tinnitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisone tablet | The dose selection of oral prednisone is the maximum daily dose based on weight for 4 days, followed by a taper every 2 days, with the maximum duration to 14 days. |
| DRUG | Ginkgo Biloba Extract | Ginkgo biloba extracts are traditional Chinese medicine, which can improve microcirculation and provide good ameliorating effects for the treatment of tinnitus |
Timeline
- Start date
- 2022-10-30
- Primary completion
- 2023-01-22
- Completion
- 2024-02-03
- First posted
- 2022-10-24
- Last updated
- 2025-02-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05591144. Inclusion in this directory is not an endorsement.